Granite Point Capital Management, L.P. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Granite Point Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$0.94 - $1.89 $280,706 - $564,399	-298,624 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$1.5 - $9.38 $147,936 - $925,093	98,624 Added 49.31%	298,624 $538,000
Q2 2020 Aug 12, 2020	BUY	$4.79 - $8.39 $958,000 - $1.68 Million	200,000 New	200,000 $1.68 Million

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $7.27B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.